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Schwann cell dedifferentiation from a myelinating to
a progenitor-like cell underlies the remarkable ability
of peripheral nerves to regenerate following injury.
However, the molecular identity of the differentiated
and dedifferentiated states in vivo has been elusive.
Here, we profiled Schwann cells acutely purified
from intact nerves and from the wound and distal re-
gions of severed nerves. Our analysis reveals novel
facets of the dedifferentiation response, including
acquisition ofmesenchymal traits and aMycmodule.
Furthermore, wound and distal dedifferentiated
Schwann cells constitute different populations, with
wound cells displaying increased mesenchymal
character induced by localized TGFb signaling.
TGFb promotes invasion and crosstalks with Eph
signaling via N-cadherin to drive collective migration
of the Schwann cells across thewound. Consistently,
Tgfbr2 deletion in Schwann cells resulted in misdir-
ected and delayed reinnervation. Thus, the wound
microenvironment is a key determinant of Schwann
cell identity, and it promotes nerve repair through
integration of multiple concerted signals.
INTRODUCTION
The adult peripheral nervous system (PNS) retains significant
regenerative potential, enabling the repair of even severe injuries
such as full transection of the nerve trunk (Chen et al., 2007).
Following a lesion to the nerve, the portion of the axons distal
to the injury site degenerates. However, unlike central nervous
system axons, damaged peripheral axons are able to regrow
and reinnervate their targets (Chen et al., 2007). This process is
underpinned by the remarkable plasticity of the PNS glia, the98 Neuron 96, 98–114, September 27, 2017 ª 2017 The Authors. Pub
This is an open access article under the CC BY license (http://creativeSchwann cells (SCs) (Jessen et al., 2015; Kim et al., 2013a). In
intact nerves, SCs are present in two differentiated states, either
myelinating large-caliber axons (myelinating SCs) or ensheath-
ing groups of small-caliber axons in Remak bundles (nonmyeli-
nating SCs). In contrast, following injury, differentiated SCs
reprogram to a progenitor-like cell. Dedifferentiated SCs switch
off the myelination program and acquire an array of new pheno-
types, which coordinately support nerve repair. These pheno-
types include 1) secretion of neurotrophic factors to promote
axonal survival, 2) clearance of myelin debris and expression
of axonal guidance and adhesive cues to generate a favorable
environment for axonal regrowth, 3) initiation of an inflammatory
response to promote wound healing, and 4) proliferation to
replace lost cells (Jessen et al., 2015).
Furthermore, upon transection injuries that generate a gap
in the nerve, dedifferentiated SCs guide regrowing axons
through the nerve bridge, a piece of connective tissue that forms
across the gap to rejoin the severed stumps (McDonald et al.,
2006). SCs from both stumps invade the bridge as multicellular
cords and migrate directionally, eventually rejoining. This gener-
ates continuous cellular conduits across the wound and along
which axons regrow to cross the gap and reinnervate the distal
stump (Jessen et al., 2015; Parrinello et al., 2010).
At the molecular level, cord migration is driven by Eph/ephrin-
mediated interactions between SCs andwound fibroblasts. Acti-
vation of EphB2 receptors on the SCs by ephrin-B ligands on
fibroblasts induces SC sorting into cords through the relocaliza-
tion of N-cadherin to cell-cell contacts in a Sox2-dependent
manner (Parrinello et al., 2010).
Seminal work over the past few decades has uncovered key
transcription factors (e.g., c-jun, sox2), epigenetic changes,
and signaling pathways (e.g., ERK, Notch) that control SC re-
programming (Arthur-Farraj et al., 2012; Hung et al., 2015;
Jessen et al., 2015; Le et al., 2005; Napoli et al., 2012; Woodhoo
et al., 2009). However, a comprehensive molecular characteriza-
tion of myelinating and dedifferentiated SCs in vivo is still
lacking. Furthermore, despite the specialized function of bridge
SCs, it remains unclear whether the reprogrammed state islished by Elsevier Inc.
commons.org/licenses/by/4.0/).
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homogeneous throughout the injured nerve or whether regional
differences in SC state may exist, particularly within the bridge.
This gap in our knowledge is largely due to the technical limi-
tations of purifying sufficient numbers of SCs for standard
downstream molecular analysis. Consistent with this, previous
investigation of the transcriptional changes associated with
nerve regeneration have been limited to analysis of whole nerves
before and after injury (Arthur-Farraj et al., 2012; Jiang et al.,
2014; Kubo et al., 2002; Le et al., 2005). However, interpretation
of this type of analysis is confounded by the cellular heterogene-
ity of nerve tissue, the pronounced inflammatory response that
ensues injury, and the difference in SC content between intact
and injured nerves (Cattin et al., 2015; Jessen et al., 2015).
Furthermore, whole-tissue approaches are not amenable to
the analysis of bridge SCs due to the extensive influx of stromal
and inflammatory cells into the nerve bridge. Nonetheless,
deciphering the SC transcriptome and its modulation by the
microenvironment is a prerequisite to the understanding of
PNS regeneration and, more generally, of the molecular basis
of somatic cell plasticity.
In this study, we developed a fluorescence-activated cell sort-
ing (FACS)-based approach to prospectively purify SCs from
mouse sciatic nerves. By combining this approach with RNA
amplification protocols, we carried out transcriptional profiling
of in vivo SCs from intact nerves and from bridge and distal
stumps of transected nerves. Our analysis reveals novel pheno-
types associated with SC reprogramming. Importantly, we also
find that bridge SCs are a distinct subpopulation of progenitor-
like SCs of increased mesenchymal character. We show that a
localized increase in TGFb signaling in the bridge underlies this
change in order to promote SC invasion into the wound. Surpris-
ingly, our studies also reveal an unprecedented crosstalk
between TGFb and EphB2, which we find is effected by tran-
scriptional regulation of N-cadherin downstream of TGFb.
Together, our findings indicate that extracellular cues from the
wound microenvironment intersect with cell-intrinsic dedifferen-
tiation mechanisms to reprogram the SC to an invasive, mesen-
chymal-like cell. They further identify TGFb as a key mediator of
peripheral nerve regeneration after transection and Eph/ephrin
signaling as a novel TGFb effector, with important implications
for the EMT, wound healing, and cancer.Figure 1. RNA Sequencing of Differentiated and Progenitor-like SCs Id
(A) Example of a regenerating sciatic nerve of tdTomSC mice collected 6 days p
collected for FACS purification is shown. tdTomato+ SCs are in red, and DAPI-st
(B) Representative FACS plots of the purification of tdTomato+ SCs from sciatic
used for gating.
(C) RNA-seq differential gene expression analysis of SCs from pooled distal stum
blue), myelination genes (red circles), SC markers (black circles), and dedifferent
(D) Functional analysis of genes differentially regulated between dSCs and iSCs.
the enrichment p values for selected GO categories (BP: biological process, CC:
ratios in each category. Circle size denotes the number of regulated genes.
(E) GSEA enrichment plots of dSCs compared to iSCs for the ‘‘epithelial mesenc
(F) Average log2 FPKM expression of the ES core, PRC, and Myc modules from (K
dSCs, as well as differentiated cells of neural origin (Astrocytes, Neurons) and plu
been median centered to allow comparison across datasets.
(G) GSEA enrichment analysis of dSCs compared to iSCs (D–I) and bSCs comp
regulation by the Prc2 complex (11–15), regulation by Myc (16-18), three ES modu
represent normalized enrichment score and colors represent the FDR q values%
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Purification of Differentiated and Progenitor-like SCs
To isolate SCs from nerve tissue, we generated Schwann-cell-
specific tdTomato reporter mice (hereafter tdTomSC) by crossing
P0A-Cre animals, which express Cre recombinase under the
control of the neural crest-specific Myelin Protein Zero (Mpz)
promoter, to Rosa26tdTomato reporter strains (Giovannini et al.,
2000; Madisen et al., 2010). Consistent with previous studies,
analysis of tdTomSCmice revealed strong tdTomato expression,
unaffected by injury, in adult sciatic nerves (Figures 1A and S1A).
Furthermore, coimmunostaining for the SC markers MBP and
p75NGFR, which specifically label myelinating and nonmyelinat-
ing SCs, respectively, confirmed that tdTomato recombination
was efficient and restricted to SCs (Giovannini et al., 2000;
Zheng et al., 2008) (Figures S1A and S1B). Thus, tdTomato is a
suitable marker for purification of differentiated and dedifferenti-
ated SCs from their in vivo microenvironment using FACS.
To this end, the right sciatic nerve of tdTomSCmice was trans-
ected and, 6 days later, the contralateral intact nerve and distal
stump of the severed nerve were collected together with the
nerve bridge to determine potential effects of the wound micro-
environment. This time point was specifically chosen because it
coincides with complete SC dedifferentiation and extensive, but
not complete, invasion into the bridge (Figure S2B) (Chen et al.,
2007; Parrinello et al., 2010). Nerve tissuewas dissociated to sin-
gle cells, and SCs were sorted from other tdTomato nerve cells
based on tdTomato expression (Figure 1B). Single cell prepara-
tions from P0A-Cre nerves were used as reference for setting
FACS gates. Acute immunostaining and Calcein labeling of
FACS-sorted tdTomato cells confirmed that tdTomato+ cells
were highly enriched for tdTomato expression, contained negli-
gible contamination of tdTomato cells, expressed the pan-SC
marker S100b, and were viable (Figures S1C and S1D). FACS
analysis of cell suspensions from all three nerve regions indi-
cated that the vast majority of the tdTomato+ but almost
none of the tdTomato cells were S100b+, further confirming
the purity of sorted tdTomato cells (Figure S1E). Furthermore,
qRT-PCR analysis indicated that tdTomato+ cells from intact
and transected nerves were enriched for the appropriate SC dif-
ferentiation (Mpz, Plp, Pmp22) and dedifferentiation (p75NGFR,entifies Novel Features of Dedifferentiation
ost-transection. A representative tiled fluorescent image of the nerve regions
ained nuclei are in blue. Dotted lines demarcate the nerve bridge.
nerves of tdTomSC mice (bottom). Control P0A-Cre;tdTomfl/fl cells (top) were
p (dSCs) and intact nerve (iSCs). Genes regulated over 2.53 (adj. p < 0.05, light
iation markers (dark blue circles) are highlighted.
Genes with dSC:iSC count ratios >2.53 (adj. p < 0.05) were selected. –log10 of
cellular components) are plotted relative to Z scores of average dSC:iSC count
hymal transition’’ and ‘‘Myc targets V1’’ MSigDB hallmarks.
im et al., 2010) for iSCs, pooled SCs isolated from the nerve bridge (bSCs), and
ripotent ES cells (ES cells) (Zhang et al., 2014; Marks et al., 2012). FPKM have
ared to iSCs (B–I) for MSigDB gene sets related to pluripotency (lines 2–10),
les (lines 1, 11, and 16), and markers of neural crest identity (19–21). Numbers
0.1 (red) or% 0.25 (orange/blue). See also Figure S1.
Sox2, c-Jun) markers, respectively (Figure S1F). Therefore, our
approach enables efficient purification of SCs from intact and
severed nerve tissue.
We next characterized the in vivo SC transcriptome by high-
thoughput sequencing of cDNA (RNA-seq). Libraries were pre-
pared from four biological replicates per nerve region using a
Smart-seq2 based protocol, generating an average of 33 3
10 reads per sample and leading to quantification of 15,000
genes (Picelli et al., 2014). Comparable transcriptome coverage
was obtained from higher-RNA-input libraries derived from
in vitro material, indicating that low RNA inputs did not compro-
mise the sensitivity of our analysis (Table S1). Moreover, repro-
ducibility of transcript level quantification between biological
repeats was high, and PCA analysis separated the samples
into three clearly distinct groups, which corresponded to nerve
region of origin (Figures S1G and S1H).
Having confirmed the quality and reproducibility of the RNA-
seq data, we first examined the transcriptional changes that
accompany dedifferentiation by comparing the transcriptomes
of SCs isolated from intact nerve (iSCs) and distal stump
(dSCs) (Tables S2 and S3). Importantly, analysis of RNA spike-
in controls was not supportive of a global relative increase in
RNA polymerase II (RNAPII) transcription levels upon dedifferen-
tiation (Figure S1I). Instead, differential expression analysis
indicated that a relatively small proportion of the SC transcrip-
tome changed significantly (1,692 genes; 1,115 with >2.5-fold
change). This entailed similar numbers of up- and downregu-
lated genes that included well-established markers for both
populations, further corroborating the validity of ourmethod (Fig-
ure 1C). Gene ontology (GO) and gene set enrichment analysis
(GSEA) revealed several distinct biological features between
differentiated and progenitor-like SCs. As expected, the tran-
scriptome of dSCs was enriched for genes involved in cell cycle,
immune recruitment, and phagocytosis, whereas GO terms
associated with myelination and nerve conduction were signifi-
cantly downregulated (Chen et al., 2007; Jessen et al., 2015)
(Figure 1D). Moreover, our analysis revealed a switch in how
SCs communicate with the surrounding nerve tissue, in that
iSCs showed increased levels of cell-cell communication genes
(cell junction), whereas dSCs favored expression of genes medi-
ating communication with the extracellular matrix (extracellular
signal and extracellular matrix). Notably, signatures of epithe-
lial-to-mesenchymal transition (EMT) and activated Myc were
among the most highly enriched GSEA gene sets in dSCs
(Figure 1E).
The EMT has been linked to both somatic cell dedifferentiation
to cancer stem cells and somatic cell reprogramming to induced
pluripotent cells (iPS) (Ye andWeinberg, 2015). The transcription
factorMyc is a crucial regulator of ES pluripotency and one of the
original Yamanaka reprogramming factors (Takahashi and
Yamanaka, 2016). Therefore, these signatures support the
notion that dedifferentiation is a reprogramming event that con-
verts SCs to progenitor-like cells (Arthur-Farraj et al., 2012). To
investigate this further, we analyzed expression of the three tran-
scriptional programs that define ES cell pluripotency (Kim et al.,
2010). These comprise targets of core pluripotency factors (i.e.,
Sox2, Nanog, Oct4, Core module), polycomb-related factors,
which repress lineage-specific genes (PRC module), and Myctarget genes (Myc module). Publicly available RNA-seq datasets
of ES cells and differentiated CNS cells (astrocytes and neurons)
served as reference transcriptomes (Marks et al., 2012; Zhang
et al., 2014) (Figure 1F). Remarkably, we found that dSCs acti-
vate Core and Myc modules while repressing the PRC module,
a behavior reminiscent of ES cells (Kim et al., 2010). In contrast,
module activity patterns of iSCs were similar to those of differen-
tiated cells. Consistent with these results, GSEA analysis indi-
cated that signatures of ES cells were highly enriched in dSCs
(Figure 1G) (Ben-Porath et al., 2008; Bhattacharya et al., 2004;
Kim et al., 2010; M€uller et al., 2008; Wong et al., 2008), whereas
signatures of the neural crest, from which the SCs derive, were
not (Simo˜es-Costa et al., 2014). These results suggest that,
although lineage characteristics are retained after injury, dedif-
ferentiation is not a reversal of the SC developmental program.
Rather, injury reprograms SCs to a stem-like state.
Distal and Bridge SCs have Distinct Molecular Features
We next compared the transcriptomes of dSCs and bridge SCs
(bSCs) (Tables S2 and S3). Interestingly, the number of differen-
tially expressed genes between bSCs and dSCs, despite both of
these being in a dedifferentiated state, was comparable to the
number detected between iSCs and dSCs (2,021 genes; 1,169
with >2.5-fold change), with an overall bias toward downregula-
tion in the bridge (Figure S2A). We generated seven gene clus-
ters by K-means clustering of expression ratios that were further
examined by GO analysis and combined with GSEA analysis of
the entire dataset (Figures 2A and 2B; Table S4). Our analysis re-
vealed a downregulation in genes essential to the repair program
in bSCs, such as genes involved in inflammation, immune
signaling, and ECMproduction, and a decrease in transcriptional
activity. In contrast, genes involved in cell division, growth, and
metabolism were strongly upregulated, suggesting that bridge
cells might have an increased proliferative capacity. To test
this more directly, we measured cell proliferation in vivo by puls-
ing tdTomSC mice with EdU for 4 hr from 4 to 10 days post-tran-
section, a timeline encompassing all stages of SC migration into
the bridge (Figure S2B). Consistent with the RNA-seq data, more
EdU+ SCs were detected in the bridge than in distal stump at all
time points (Figures 2C and 2D), indicating that bSCs are more
proliferative than their distal counterparts.
GSEA analysis indicated that the EMT and active Myc signa-
tures detected upon transition from iSCs to dSCs were further
enriched in bSCs, indicative of a potential change in differentia-
tion state (Figure 2B). Indeed, closer examination of the bridge
EMT signature revealed that bSCs had a more pronounced
mesenchymal signature than did dSCs, with many EMT genes
being more highly expressed in bSCs than in dSCs (Figure 2E).
Of note, a similar decrease in Cdh1 expression, a hallmark of
the EMT, was detected in both dSCs and bSCs (dSCs/iSCs:
5.13, p = 1.52e6; bSCs/iSCs: 3.33, p = 2.5e3). To further
assess these differences and determine whether they are
distinctive properties of bSCs throughout repair, we carried out
time-course analysis of bSC and dSC transcriptomes by RNA-
seq (Table S6). SCs were acutely FACS-sorted from the bridge
and distal stumps of single transected or contralateral intact
nerves. dSCs were analyzed at days 1, 2, 4, 6, 8, and 10;
nerve-matched bSCs were analyzed from day 4, the earliestNeuron 96, 98–114, September 27, 2017 101
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time point at which invasion into the bridge occurs, up to day 10
(Figure S2B). Importantly, this analysis revealed that the differ-
ences in gene expression between bSCs and dSCs observed
at day 6 are established as soon as bSCs enter the bridge and
are maintained over time (Figures 2F and 2G). Similarly, genes
associated with repair (k-means clusters 1 and 7) were downre-
gulated in bSCs at all time points (Figures S2C and S2D). In
contrast, the increase in EMT genes was restricted to time points
at which bSCs invade into the bridge, in that this increase began
at day 4, peaked at day 6, and subsided at day 8, when invasion
is largely complete (Figures 2H and S2B). Importantly, this
enhanced EMT signature was never detected in dSCs, indicating
that it is a bridge-specific phenotype (Figure 2H). Together, these
results indicate that bridge SCs are a molecularly distinct sub-
population of dedifferentiated cells with reduced repair-promot-
ing ability and with increased proliferation and differentiation
toward the mesenchymal lineage.
TGFb Signaling Reprograms Bridge SCs to Invasive
Mesenchymal-like Cells
The ECM and cellular composition of the bridge microenviron-
ment is markedly different from the rest of the injured nerve (Cat-
tin et al., 2015; McDonald et al., 2006; Parrinello et al., 2010). We
therefore hypothesized that wound-specific extracellular signals
might underlie the distinct molecular profile of bSCs. TGFb is a
particularly good candidate for this because it is a master regu-
lator of the EMT and wound healing and has been previously
linked to PNS regeneration (D’Antonio et al., 2006; Lamouille
et al., 2014; reviewed in Mirsky et al., 2008). We therefore exam-
ined TGFb activity in the regenerating nerve using two ap-
proaches. First, we coimmunostained wild-type nerves 6 days
after cut for phosphorylated Smad3 (p-Smad3), the canonical
downstream effector of the TGFb pathway (Shi and Massague´,
2003), and also S100b, which labels all SCs in the injured nerve
(Figure S1E). Consistent with previous reports of increased
TGFb levels upon injury, p-smad3+/S100b+ cells could be de-
tected throughout the cut nerve, but their number strongly
increased in the bridge, indicating that TGFb signaling activity
is maximal in bSCs (Figures 3A and 3B) (Mirsky et al., 2008).
Similar results were obtained in tdTomSC nerves (Figure S3A).
Second, we interrogated the in vivo SC transcriptome for signa-
tures of active TGFb signaling. To generate Schwann-cell-spe-
cific TGFb signatures, we performed RNA-seq of in vitro ratFigure 2. Bridge and Distal SCs Have Distinct Molecular Signatures
(A) Seven k-means clusters of dSC:iSC, bSC:iSC and bSC:dSC expression rat
condition. Selected functional categories enriched in each cluster are shown. Cl
(B) GSEA enrichment analysis of preranked bSC:dSC ratios for MSigDB hallm
enrichment scores (NES). Categories with negative or positive NES are down- or
genes in each category and circle colors represent FDR q values as indicated.
(C) Representative EdU staining (green) of actively proliferating tdTomato+ SCs i
(D) Quantification of EdU+/tdTomato+ SCs relative to total tdTomato+ SCs in the b
nerve (mean ± SEM). n = 6 at day 6 and n = 3 at days 4, 8, and 10, **p < 0.01 an
(E) Hierarchical clustering of log2 expression ratios for genes belonging to th
upregulated (adj. p < 0.05) in bSCs compared to iSCs are shown. Rows are dSC
(F–H) RNA-seq time course analysis of dSC and bSC gene expression changes a
are plotted relative to time after injury for the genes (F) upregulated in bSCs relat
S2A, and (H) belonging to the EMT signature from (E). Boxes denote the interquar
represent dSC:iSC ratios for all genes as a reference. Data from cells isolated froSCs that were cultured in the presence or absence of recombi-
nant TGFb for 16 hr. Transcripts differentially expressed in
response to TGFb treatment were used as signature gene sets
for GSEA analysis of the in vivo datasets (Table S5). As shown
in Figure 3C, we found that the Schwann-cell-specific TGFb
signatures were enriched significantly in bSCs, but not in
iSCs or dSCs. To further assess TGFb activity throughout the
formation and invasion of bSC cords, we next examined
TGFb signature genes in the RNA-seq time course data. We
found that TGFb target gene expression is increased in bSCs
relative to dSCs at all time points, confirming that TGFb
signaling is highest in invading bSCs within regenerating cut
nerves (Figure 3D). Consistent with these findings, TGFb
mRNA levels were highly enriched in the bridge microenviron-
ment; this was judged by qRT-PCR analysis of acutely FACS-
sorted tdTomato bridge cells compared to tdTomato+ SCs
(Figure S3B). Furthermore, the bridge contained large numbers
of p-Smad3+/S100b cells—many of which were fibroblasts
and endothelial cells, the most abundant cell types in this re-
gion—and fibroblasts expressed higher levels of TGFb than
SCs in vitro (Figures S3C–S3E) (Cattin et al., 2015; Parrinello
et al., 2010).
To understand the functional role of TGFb signaling in the
bridge, genes that were commonly upregulated in both bSCs
and TGFb-treated rat SCs were compared to GSEA Hallmark
gene sets. This identified the EMT signature as the most signifi-
cantly enriched gene set (p = 5.86e15), indicating that TGFbmay
be primarily involved in driving the increased mesenchymal
transition of bSCs. In agreement with this, qRT-PCR analysis
confirmed that many bSC-specific EMT genes were TGFb tar-
gets (Figure S4A).
Next, we assessed the effects of loss of TGFb function in
bSCs. We ablated TGFb receptor (TGFR) activity specifically in
SCs by crossing the P0A-Cre strain to mice carrying conditional
Tgfbr2 alleles, which encode for the obligatory component of the
TGFb receptor complex TGFb receptor 2 protein (hereafter
referred to as Tgfbr2DSC) (Leve´en et al., 2002). Genomic recom-
bination of the Tgfbr2-floxed alleles in the adult sciatic nerves of
Tgfbr2DSCmice was confirmed by PCR analysis (Figure S4B). To
assess recombination efficiency and functional inactivation of
the pathway, Tgfbr2fl/fl and Tgfbr2DSC nerves were immuno-
stained for p-smad3 and S100b, as in Figure 3. This showed effi-
cient, but variable, SC-specific loss of TGFR activity (60% toios. Colors represent the mean of log2 expression ratios in each cluster and
uster numbers from top to bottom: 2,6,3,4,7,1,5, as in Table S4.
arks. Gene sets with FDR q values <0.25 are plotted relative to normalized
upregulated, respectively, in bSCs. Circle size denotes the number of enriched
n the bridge and distal stump 6 days post-transection.
ridge and distal nerves at 4, 6, 8, and 10 days post-transection and in the intact
d ***p < 0.001, two-tailed paired Student’s t test.
e ‘‘epithelial mesenchymal transition’’ MSigDB hallmark. Genes significantly
:iSC, bSC:iSC, and bSC:dSC log2 ratios from top to bottom.
fter sciatic nerve transection. dSC:iSC (blue) or bSC:iSC (red) expression ratios
ive to dSCs from figure S2A, (G) downregulated in bSCs relative to dSCs from
tile range, and black strikes denote the median of ratios in the list. Open boxes
m single nerves are shown; n = 3–4 per time point. See also Figure S2.
Neuron 96, 98–114, September 27, 2017 103
 D
is
ta
l  
   
   
   
   
   
   
   
   
   
   
   
   
Br
id
ge
   
   
   
   
   
   
   
   
   
   
   
 P
ro
xi
m
al
S100β/pSmad3 S100β/DAPI
0
20
40
60
80
%
 p
Sm
ad
3/
S1
00
β+
 
Sc
hw
an
n 
C
el
ls
*** ***
Pr
ox
im
al 
Br
idg
e
Di
sta
l
0.35
0          5,000 10,000
0
E
nr
ic
hm
en
t S
co
re
 (E
S
)
Gene Set:                    TGFβ UP                                       TGFβ DN    
0          5,000 10,000
0
-0.6
A B
C
NES 1.337
q-val 0.083
GSEA TGFβ Schwann Cell signature bSC vs iSC and dSC
NES -1.692
q-val 0.0052
50μm
lo
g 2
 
ex
pr
es
sio
n 
ra
tio
 re
la
tiv
e
 to
 iS
C
Days after transection
D
−1.0
−0.5
0.0
0.5
1.0
1 2 4 6 8 10
Figure 3. TGFb Signaling Is Increased in the Nerve Bridge
(A) p-Smad3 expression in the proximal (top), bridge (middle), and distal (bottom) nerve 6 days post-transection. Paraffin sections were stained for p-Smad3
(DAB), the SC marker S100b (red), and DAPI (blue). White arrowheads indicate p-Smad3 colocalization with SC nuclei.
(B) Quantification of p-Smad3-expressing SCs in each region (mean ± SEM). n = 9, ***p < 0.001, one-way ANOVA with Bonferroni correction.
(C) GSEA enrichment plots of bSCs compared to dSCs and iSCs for the SC-specific transcriptional response to TGFb (this study). TGFb UP and TGFb DN gene
sets are up- or downregulated, respectively, by TGFb.
(D) RNA-seq time course analysis of dSC or bSC gene expression changes after sciatic nerve transection. dSC:iSC (distal:intact; blue) or bSC:iSC (bridge:intact;
red) expression ratios are plotted relative to time after injury for the 30 TGFb UP genes with the highest significant bSC:dSC ratios in the dataset in (C) (p < 0.05).
Boxes denote the interquartile range, and black strikes denote the median of ratios in the list. Open boxes represent dSC:iSC expression ratios for all genes as a
reference. Data from cells isolated from single nerves are shown; n = 3–4 per time point. See also Figure S3.80% of all SCs), consistent with previous studies (Figures S4C
and S4D) (Giovannini et al., 2000; Zheng et al., 2008). Impor-
tantly, ultrastructural analysis by electron microscopy of intact
Tgfr2DSC adult sciatic nerves revealed that they were similar to
controls, indicating that this model can be used to study PNS104 Neuron 96, 98–114, September 27, 2017regeneration in the absence of confounding developmental de-
fects (Figures S4E–S4G).
Six days following transection, Tgfbr2DSC and P0A-Cre
Tgfbr2fl/fl control nerve bridges were immunostained for S100b,
and SC regrowth from the proximal stump was examined by
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quantifying the average SC cord length and maximal migrated
distance into the bridge. This revealed a marked defect in bridge
regeneration in Tgfbr2DSC compared to controls (Figure 4A). In
control nerves, numerous parallel SC cords invaded and
migrated robustly into the bridge, as expected (McDonald
et al., 2006; Parrinello et al., 2010). In contrast, in Tgfbr2DSC
mice, SC invasion was uneven and severely stunted, with cells
extending much shorter distances from the proximal stump (Fig-
ures 4B and 4C). To determine whether this phenotype de-
pended on loss of TGFb-induced mesenchymal traits, we
crossed Tgfbr2DSC to tdTomato reporter mice, FACS-sorted
bSCs from day-6 cut nerves of the resulting tdTom;Tgfbr2DSC
and littermate controls, and measured expression of bSCs-
specific EMT genes by qRT-PCR. We found that the EMT signa-
ture was significantly downregulated in bSCs, but not in dSCs
of Tgfbr2DSC (Figures 4D, S4J, and S4K). In addition, we carried
out Boyden chamber assays and found that TGFb treatment
significantly increases the ability of cultured rat and Tgfbr2fl/fl
mouse SCs to invade through fibronectin, a major component
of the bridge ECM (Figure 4E) (Cattin et al., 2015). In contrast,
although SCs themselves produce TGFb (Figure S3E), neither
pharmacological inhibition of TGFR in rat cells using two
highly selective inhibitors (Akhurst and Hata, 2012) nor genetic
deletion of Tgfbr2 in mouse SCs that were freshly isolated from
Tgfbr2fl/fl mice affected invasion (Figures 4F, S4H, and S4I).
Together, these results indicate that basal TGFR signaling is
dispensable for sustaining the invasive ability of SCs. Rather,
activation of TGBR by extrinsic TGFb in the bridge enhances
SC invasiveness.Figure 4. TGFb Drives SC Invasion into the Bridge
(A) Representative immunofluorescence staining for the SCmarker S100b (green)
P0A-Cre control littermates Tgfbr2fl/fl 6 days post-transection. Nuclei are stained
nerve bridge.
(B) Average length of the SC cords from the Tgfbr2DSC and Tgfbr2fl/fl cut nerves from
paired Student’s t test.
(C) Maximal migrated distance of the SC cords from Tgfbr2DSC and Tgfbr2fl/fl cut n
two-tailed paired Student’s t test.
(D) qRT-PCR analysis of the bridge-specific mesenchymal gene signature in
tdTom;Tgfbr2DSC mice. Boxplots represent log2 bSC:dSC expression ratios of 2
Tgfbr2DSC (purple bar, n = 5) mice are shown; pWilcoxon = 0.00024. The whiskers
quartile range from the box.
(E) SC invasion through fibronectin-coated Boyden chambers in the absence or pr
were treated with vehicle (blue bar) or TGFb (purple bar, 10 ng/mL) (mean ± SEM
(F) SC invasion through fibronectin-coated Boyden chambers upon inhibition of TG
LY2157299 (LY; purple hatched bar) or SD208 (SD; purple spotted bar) for 24 hr pr
lines) or knockout (Tgfbr2/; purple vertical lines) (mean ± SEM). n = 3.
(G) EdU incorporation in the bridges of tdTom;Tgfbr2fl/fl (blue bar, n = 5) and tdTom
in tdTom;Tgfbr2DSC is normalized to controls (mean ± SEM).
(H) EdU incorporation in rat SCs treated with vehicle (Control, blue bar) or TGFb (TG
Student’s t test.
(I) Representative immunofluorescence staining for the axonal marker neurofilam
mice and P0A-Cre control littermates (Tgfbr2fl/fl) 6 days post-transection (Top). D
bottom panels show axonal tracings of images from the top panels obtained in N
(J) Angles of axonal regrowth relative to the long axis of the nerves. Means ± SE
Tgfbr2fl/fl and n = 13 for Tgfbr2DSC, ***p < 0.001, two-tailed paired Student’s t tes
(K) Analysis of distal stump reinnervation 6 weeks post-transection in Tgfbr2fl/fl a
nerves are shown.
(L) Quantification of neurofilament staining in the distal nerves of Tgfbr2fl/fl and
quantification in ImageJ. Data are normalized to Tgfbr2fl/fl controls (blue bar) ± S
Figure S4.
106 Neuron 96, 98–114, September 27, 2017TGFb was shown to drive proliferation of cultured SCs in the
presence of Neuregulin-1, a key SC mitogen (Parkinson et al.,
2001). This raised the possibility that wound TGFb might also
be responsible for the increased proliferation of bSCs. We there-
fore measured EdU incorporation in bSCs of tdTom;Tgfbr2DSC
and control mice. As shown in Figure 4G, we found no significant
difference in the number of EdU+/tdTomato+ bSCs, indicating
that TGFb does not regulate SC proliferation within the bridge.
Consistent with this, TGFb treatment of SCs cultured in serum,
a condition that mimics the wound environment, did not signifi-
cantly affect their proliferation (Figure 4H). We conclude that
TGFb induces a specialized mesenchymal transition in bSCs
to increase their invasiveness, whereas bSCs proliferation is
TGFb independent.
TGFb Potentiates and Enables Eph-Dependent SC
Sorting
While analyzing the regenerating nerve bridge of Tgfr2DSC, we
noticed that SC cord migration into the bridge was highly disor-
ganized. As regrowing axons comigrate with SCs from the prox-
imal stump, we examined whether this aberrant SC migratory
pattern also affected axons (Cattin et al., 2015; McDonald
et al., 2006; Parrinello et al., 2010). Immunostaining for axonal
markers revealed that whereas in control mice axonal regrowth
into the bridge was directed toward the distal stump, regrowing
Tgfbr2DSC axons were disordered and misdirected. Indeed,
quantification of the angles of axonal regrowth relative to the
long axis of the nerve showed a marked increase in the percent-
age of axons that grew at >45 angles in Tgfbr2DSC compared toin longitudinal sections of regenerating proximal stumps of Tgfbr2DSCmice and
with DAPI. Dashed lines mark the border between the proximal stump and the
(A) (mean ± SEM). n = 6 for Tgfbr2fl/fl, n = 9 for Tgfbr2DSC, **p < 0.01, two-tailed
erves from (A) (mean ± SEM). n = 6 for Tgfbr2fl/fl, n = 9 for Tgfbr2DSC, **p < 0.01,
bSCs and dSCs FACS-sorted from single nerves of tdTom;Tgfbr2fl/fl and
4 bridge-specific EMT genes. Pooled data for Tgfrb2fl/fl (blue bar, n = 6) and
extend to the most extreme data point, which is no more than 1.53 the inter-
esence of TGFb. Rat SCs (rSC, solid bars) andmouse SCs (mSC, hatched bars)
). n = 3, *p < 0.05, ***p < 0.001, one-way ANOVA.
FR signaling. Rat SCs (rSC) were left untreated or treated with TGFR inhibitors
ior to the assay. Mouse SCs (mSC) were either wild-type (Tgfbr2fl/fl, blue vertical
;Tgfbr2DSC (purple bar, n = 4) mice 6 days post-transection. EdU incorporation
Fb, purple bar) for 16 hr in vitro (mean ± SEM). n = 3, p = 0.14, two-tailed paired
ent (red) in longitudinal sections of regenerating proximal stumps of Tgfbr2DSC
ashed lines mark the border between the proximal stump and the bridge. The
euronJ.
M of the percentage of axons at angles >45 per group are shown. n = 6 for
t.
nd Tgfbr2DSC mice. Representative images of neurofilament staining in distal
Tgfbr2DSC mice shown in (K). Axon density was measured by fluorescence
EM n = 4 for each set, **p < 0.01, two-tailed paired Student’s t test. See also
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Figure 5. TGFb Crosstalks with EphB2 to Modulate SC Sorting
(A) Fluorescence images of rat SCs stained for S100b (green) plated on Fc control or ephrin-B2-Fc ligand in the presence or absence of TGFb.
(B) Quantification of cell sorting shown in (A) (mean ± SEM). n = 3, **p < 0.01; ***p < 0.001, Fisher’s exact test.
(C) Quantification of cell sorting as in (B) of rat SCs plated on Fc or ephrin-B2-Fc in the absence or presence of TGFR inhibitors LY2157299 (LY) or SD208 (SD). Cell
sorting data is represented as mean ± SEM n = 3, ***p < 0.001, Fisher’s exact test.
(D) Quantification of cell sorting as in (B) for wild-type (Tgfbr2fl/fl) and knockout (Tgfbr2/) mouse SCs plated on Fc or ephrin-B2-Fc (mean ± SEM). n = 3, *p < 0.05;
***p < 0.001, Fisher’s exact test.
(E) Representative fluorescence images of rat SCs treated with Scr siRNA or siRNA against Smad4 (siSmad4) and cultured on Fc or ephrin-B2-Fc recombinant
proteins.
(F) Quantification of cell sorting from (E) (mean ± SEM). n = 3, ***p < 0.001, Fisher’s exact test. See also Figure S5.controls (Figures 4I and 4J). The defect in SC and axonal migra-
tion into the bridge observed in Tgfbr2DSCmice resulted in a sig-
nificant decrease in reinnervation of the distal stump at 6 weeks
post-transection (Figures 4K and 4L). However, no significant
differences in the number or remyelination of distal axons
were detected by electron microscopy at 3 months, suggesting
that compensatory mechanisms enable long-term regeneration
(data not shown).
This phenotype is remarkably similar to the regeneration
defect of EphB2 knockout mice, raising the interesting possibility
that the two pathways might interact in vivo (Parrinello et al.,
2010). We previously reported that treatment of cultured SCswith recombinant ephrin-B2 ligands recapitulates their in vivo
cell sorting behavior in response to bridge fibroblasts, resulting
in the grouping of SCs into defined clusters (Parrinello et al.,
2010). We therefore used this assay to examine effects of
TGFb on EphB2-mediated SC sorting. SCs were cultured on
control Fc or ephrin-B2-Fc proteins in the presence or absence
of TGFb for 16 hr, and clustering was scored following immuno-
staining for S100b. Surprisingly, we found that TGFb induced
mild clustering on its own and significantly enhanced cell sorting
in response to ephrin-B2, leading to larger and more compact
clusters (Figures 5A and 5B). Furthermore, we examined the
effects of loss of TGFb activity on ephrin-B2-induced cell sortingNeuron 96, 98–114, September 27, 2017 107
in rat SCs cultured in the presence or absence of TGFR inhibitors
and in freshly isolated Tgfbr2/ and Tgfbr2fl/fl mouse cells. In
both experiments, cell sorting was impaired (Figures 5C and
5D), indicating that EphB2 is strictly dependent on TGFb
signaling for function. These effects were mediated by Smad-
dependent transcription downstream of TGFR because siRNA
to the Co-Smad Smad4, which is required for nuclear transloca-
tion and transcriptional activity of p-Smads and which specif-
ically inactivated TGFb signaling in our system (Figure S5A),
also severely disrupted SC clustering in response to ephrin-B2
(Figures 5E and 5F) (Shi and Massague´, 2003). Efficiency and
specificity of the knockdown were confirmed by western blot
analysis and parallel cell-sorting experiments, respectively, us-
ing a second independent siRNA oligo (Figures S5B, S5C, 6B,
and 6I). Thus, TGFb potentiates EphB2-dependent cell sorting,
and its absence abolishes EphB2 function.
N-Cadherin Mediates TGFb/Eph Crosstalk
We next determined the mechanisms by which TGFbmodulates
the EphB2 pathway. On activation by ephrin-B ligands, EphB2
becomes phosphorylated (p-EphB2) and induces cell sorting
by post-translationally modifying and stabilizing the pluripotency
factor Sox2, which, in turn, increases Schwann cell-cell adhe-
sion via relocalization of N-cadherin to cell-cell contacts (Parri-
nello et al., 2010). We therefore asked whether TGFb directly
modulates any of these pathway components. Western blot
analysis indicated that EphB2 phosphorylation was largely unaf-
fected by either TGFb treatment or Smad4 knockdown (Figures
6A–6C). Of note, a small increase in phosphorylation levels
was detected in TGFb samples. However, it was not accompa-
nied by EphB2 internalization, a hallmark of activation, indicating
that it did not elicit significant signaling (Figures 6A and 6B). Simi-
larly, whereas ephrin-B2 stimulation increased Sox2 levels as
expected (Parrinello et al., 2010), TGFb treatment did not (Fig-
ure S6). In contrast, analysis of N-cadherin in cell-sorting assays
revealed marked regulation by TGFb. TGFb alone relocalized
N-cadherin to Schwann cell-cell contacts to a similar extent as
ephrin-B2 ligands alone, and the two ligands combined syner-
gised to potentiate this effect (Figures 6D and 6E). Conversely,
treatment with TGFR inhibitors or Smad4 knockdown abrogated
the ability of ephrin-B2 to redistribute N-cadherin (Figures 6F and
6G). This was paralleled by changes in N-cadherin protein levels;
TGFb increased N-cadherin levels, whereas Smad4 knockdown
and inhibitor treatment strongly reduced basal N-cadherin
levels, depleting both soluble and actin-bound N-cadherin pools
(Figures 6H and 6I).
N-cadherin is a key EMT gene and a well-established TGFb
target (Yang et al., 2015). To test whether TGFb may regulate
Cdh2, the N-cadherin encoding gene, at the transcriptional level,
we performed qRT-PCR analysis. We found that whereas Cdh2
mRNA levels were unaffected by treatment with ephrin-B2 on its
own, as expected, exposure to TGFb alone or with ephrin-B2
significantly increased Cdh2 expression. Inhibition of TGFb
signaling had the opposite effect, reducing Cdh2 mRNA levels
by about 50% (Figures 6J–6L) (Parrinello et al., 2010).
To functionally assess whether transcriptional regulation of
N-cadherin mediates the TGFb/EphB2 crosstalk, we carried
out gain- and loss-of-function cell sorting experiments. First,108 Neuron 96, 98–114, September 27, 2017we knocked down Cdh2 using a concentration of siRNA oligos
sufficient to block its increase in response to TGFb but insuffi-
cient to significantly alterCdh2 basal levels and thus inhibit basal
ephrin-B2-induced clustering (Figure S7A). This partial Cdh2
knockdown abolished clustering in TGFb samples and reduced
cell sorting to the levels of ephrin-B2-treated samples in cells
treated with both ligands (Figure 7A). Then we ectopically
increased Cdh2 expression by adenoviral transduction to a level
similar to TGFb treatment (Ad-Cdh2 cells, Figure S7B) and quan-
tified cell sorting in the presence or absence of ephrin-B2 relative
to GFP-transduced controls (Ad-Gfp cells). We found that un-
treated Ad-Cdh2 cells phenocopied TGFb-treated Ad-Gfp cul-
tures and that treatment of Ad-Cdh2 cells with ephrin-B2 ligands
closely mimicked the synergistic effects of TGFb and ephrin-B2
treatment combined (Figure 7B). Furthermore, increased Cdh2
levels fully rescued ephrin-B2-induced cell sorting in the pres-
ence of TGFR inhibitors (Figure 7C). Together, these results indi-
cate that the increase in Cdh2 expression is both necessary and
sufficient to potentiate cell sorting downstream of TGFb.
Finally, we examined the relevance of these findings to
TGFb-mediated nerve regeneration in vivo. We first assessed ef-
fects of Tgfbr2 loss on SC cords in the bridge. We found a
decrease in the number of SCs in cords and an increase in single
cells indicative of impaired EphB2-mediated cell sorting (Figures
7D and 7E). Then we analyzed N-cadherin expression in vivo.
Consistent with a bridge-specific function, N-cadherin levels
were 1.96-fold higher in bSCs than in dSCs in our RNA-seq data-
set (Figure 7F). In addition, qRT-PCR analysis indicated that,
although variable due to the low RNA input and the variable
recombination efficiency seen in the Tgfbr2DSC mice, Cdh2
levels trended toward downregulation in Tgfbr2DSC bSCs com-
pared to Tgfbr2fl/fl bSCs, but remained unchanged in dSCs (Fig-
ure 7G). At the protein level, immunofluorescence analysis
indicated that whereas N-cadherin was highly enriched at
Schwann cell-cell contacts in the bridges of control nerves, the
protein appeared mislocalized and more diffuse in Tgfbr2DSC
nerves (Figure 7H). This difference was not due to axonal Cdh2
expression; colocalization of neurofilament and N-cadherin pro-
teins was minimal, and similar numbers of axonal fibers were
seen in both genotypes (Figure S7C). Together, these observa-
tions confirm that N-cadherin is a TGFb effector within regener-
ating nerves in vivo.
DISCUSSION
Since the groundbreaking discovery that differentiated somatic
cells can be induced to become pluripotent by overexpression
of defined transcription factors, the molecular basis of experi-
mental reprogramming has been the focus of intense investiga-
tion (Merrell and Stanger, 2016; Takahashi and Yamanaka,
2016). However, increasing evidence suggests that, at least in
some adult mammalian tissues, reprogramming can also occur
naturally in response to injury (Merrell and Stanger, 2016). One
of the most striking examples of physiological reprogramming
is the dedifferentiation of SCs that occurs in peripheral nerve
regeneration (Jessen et al., 2015; Kim et al., 2013a).
Here we developed a method to isolate pure populations of
differentiated and dedifferentiated SCs from their in vivo nerve
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microenvironment, enabling us to define the molecular profile of
both states. This revealed several new features of SC reprog-
ramming, including the acquisition of mesenchymal traits. The
EMT has emerged as a hallmark of cell fate conversion in devel-
opment, tumorigenesis and somatic cell reprogramming (Ye and
Weinberg, 2015). Our work indicates that natural reprogramming
is also accompanied by passage through an EMT-like transition.
This finding is further underscored by a recent study on leprosy
(Masaki et al., 2013), which demonstrated that the leprosy bac-
teria reprograms SCs to mesenchymal-like stem cells by down-
regulating lineage determinants and upregulating EMT genes.
Consistent with previous reports, we found SC marker gene
expression to be retained in injury-induced dedifferentiation.
Indeed, our analyses showed that both bSCs and dSCs remain
S100b+ and express significant amounts of Sox10 mRNA (Fig-
ures S1E and S7D) (Chen et al., 2007; Jessen et al., 2015). Inter-
estingly, however, we found that Sox10 mRNA levels were
reduced to similar extents in both dSCs and bSCs compared
to iSCs (Figure S7D). Thus, amesenchymal-like transition is likely
not idiosyncratic to leprosy infection, but a physiological
response to injury, which is exploited and augmented by the
bacteria.
The identification of a partial mesenchymal transition provides
important insights into the nature of SC dedifferentiation. Tradi-
tionally, dedifferentiation has been considered as a reversal to
an earlier developmental stage in the SC lineage (Chen et al.,
2007). However, an important study recently challenged this
view. The authors demonstrated that dedifferentiated SCs upre-
gulate a specialized repair-promoting transcriptional program
orchestrated by c-jun and suggested that injury reprograms
cells to a ‘‘repair cell’’ (Arthur-Farraj et al., 2012). Our analysis
supports this idea and confirms that dedifferentiated SCs are
more closely related to ES cells than their developmental pro-
genitors, the neural crest. It also uncovers acquisition of mesen-
chymal traits as an additional molecular feature of the repair
cell. Interestingly, the mesenchymal program was not alteredFigure 6. The TGFb/EphB2 Crosstalk Is Mediated by N-Cadherin
(A) Western blot analysis of p-EphB2 and total EphB2 levels in rat SCs seeded o
ephrin-B2-Fc and TGFb combined for 16 hr. b-actin is used as a loading control
(B) Western blot analysis of p-EphB2 and total EphB2 levels in rat SCs treated w
ephrin-B2-Fc (eB2-Fc) ligands for 16 hr. Smad4 indicates knock down efficiency
(C) Densitometric quantification of western blots shown in (A) and (B) obtained in
(D) Representative confocal images of rat SCs treated with the indicated ligands
(E) Quantification of N-cadherin fluorescence at cell-cell junctions in the conditio
(mean ± SEM). n = 3, **p < 0.01; ***p < 0.001, two-tailed paired Student’s t test.
(F) Quantification of N-cadherin fluorescence at cell-cell junctions in SCs treated
(LY) and SD208 (SD) TGFR inhibitors. Means ± SEM are shown; n = 3, ***p < 0.0
(G) Quantification of N-cadherin fluorescence at cell-cell junctions in Scr and Sma
shown; n = 3, ***p < 0. 001, one-way ANOVA.
(H) Western blot analysis of actin-bound and soluble N-cadherin in SCs cultured o
and SD208 (SD) TGFR inhibitors. b-actin is shown for loading.
(I) Western blot analysis of total N-cadherin in Scr and Smad4-knockdown SCs
eB2-TGFb). Smad4 indicates knockdown efficiency and b-actin loading.
(J) Quantitative RT-PCR analysis of Cdh2 levels in SCs treated with Fc, TGFb, eph
relative to Fc-treated controls are shown (mean ± SEM). n = 6, **p < 0.01, two-ta
(K) qRT-PCR analysis of Cdh2 levels in SCs cultured in the absence (Control) or p
are shown. n = 8, ***p < 0.001, two-tailed paired Student’s t test.
(L) Quantitative RT-PCR analysis of Cdh2 levels in SCs treated with Scr siRNA o
two-tailed paired Student’s t test.
110 Neuron 96, 98–114, September 27, 2017in c-Jun knockout mice, suggesting that other EMT-specific
transcription factors are likely involved (Arthur-Farraj et al.,
2012). Consistent with this idea, c-jun expression was not
affected in bSCs and dSCs from Tgfbr2DSC mice (data not
shown), whereas the EMT factors Zeb1, Sox9, and HMGA2
were all upregulated in dedifferentiated SCs (Tables S2 and
S3) (Lamouille et al., 2014).
The ability to carry out RNA-seq on minute numbers of cells
purified from the in vivo nerve enabled us to compare the tran-
scriptomes and ES modules of distal and bridge cells. We found
that bSCs and dSCs are distinct cell populations with different
transcriptomes and repair features, indicating that the microen-
vironment is a key regulator of the dedifferentiation program.
Bridge cells switch off repair genes, increase expression of
mesenchymal and Myc target genes, and proliferate more
extensively than their distal counterparts. Intriguingly, this tran-
scriptional profile is reminiscent of partially dedifferentiated
cancer cells, suggesting that the wound microenvironment
may promote a cancer-like phenotype (Kim et al., 2010; Ye
and Weinberg, 2015). A link between wounding and cancer is
well established in many tissues, including the PNS (Ribeiro
et al., 2013; Zhu et al., 2016). Our results reinforce this link
and suggest that modulation of cell plasticity may be a key
mechanism by which injury sensitizes normal cells to tumori-
genesis. They might also explain recent findings that nerve
injury induces neurofibroma formation selectively at the wound
site in a mouse model of neurofibromatosis type 1 (Ribeiro
et al., 2013).
We identified TGFb as an important mediator of the bSC
phenotype. Although TGFb signaling has been previously linked
to the regulation of SC proliferation, apoptosis, and myelination,
its role in nerve regeneration had not been previously assessed
(D’Antonio et al., 2006; reviewed inMirsky et al., 2008; Parkinson
et al., 2001). We showed that TGFb signaling is strongly
increased across many cell types within the bridge and exploited
our conditional, SC-specific Tgfbr2 knockout model ton Fc control or ephrin-B2-Fc ligands (eB2-Fc) in the presence of TGFb or with
.
ith Scr siRNA or siRNA against Smad4 (siSmad4) and seeded on Fc control or
and b-actin loading.
FiJi (mean ± SEM), n=3.
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ns shown in (D). Bar graphs show pixel intensities normalized by cell number
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01, one-way ANOVA.
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selectively study its role in bSCs. We found that TGFb exerts two
highly interrelated and synergistic functions in PNS repair that
are specific to bridge SCs: it reprograms bSCs to an invasive,
mesenchymal-like cell type to drive invasion into the wound,
and it concomitantly enhances EphB2-mediated cell sorting to
promote directional collective migration. Together, these pheno-
types drive repair through the hostile bridgemicroenvironment to
enable peripheral nerve regeneration.
However, consistent with a previous study, TGFb signaling
was dispensable for bSC proliferation, indicating that signals
other than TGFb are responsible (D’Antonio et al., 2006). Our
data suggest that TGFb is also not a key regulator of the
increased Myc activity detected in the bridge. Indeed, although
TGFb increased Myc expression in vitro, the overlap in differen-
tially expressed Myc target genes between TGFb-treated SC
and bSCs-specific genes was minimal (Tables S2 and S5). It
will be important to identify the signals that drive proliferation
and Myc within the wound in the future.
Whereas the ability of TGFb to induce a mesenchymal tran-
sition is well established, a crosstalk with Eph signaling has
never been observed (Xu et al., 2009). Remarkably, TGFb
not only enhanced cell sorting downstream of EphB2 but
was also necessary for EphB2 function. The crosstalk was
mediated by the EphB2 effector N-cadherin, which we show
is also a TGFb target. Overall, our mechanistic studies sug-
gest a model whereby TGFb enhances Eph effects by main-
taining high N-cadherin protein levels within bSCs. Upon acti-
vation by wound fibroblasts, Eph signaling relocalizes
N-cadherin to cell-cell contacts, leading to robust SC sorting
and directional migration. In contrast, in the absence of
TGFb signaling, N-cadherin expression decreases to levels
that are insufficient for Eph-mediated cell sorting, resulting
in disorganized migration of the SCs and their accompanying
axons.
In summary, our findings indicate that dedifferentiation is a
multifaceted process controlled by the interplay of cell-intrinsic
programs and cell-extrinsic signals. Following injury, neuronal
degeneration relieves prodifferentiative axonal signals, thereby
triggering SC dedifferentiation through activation of cell-intrinsic
transcriptional programs. Extrinsic signals from the microenvi-
ronment then superimpose on these programs in a context-Figure 7. An Increase in N-Cadherin Levels Mediates TGFb Effects on
(A) Quantification of cell sorting in Scr or partial Cdh2 knockdown in rat SC cultu
indicated. Cell sorting data is represented as mean ± SEM. n = 3, **p < 0.01; ***p
(B) Quantification of cell sorting in rat SCs transduced with adenoviruses encoding
TGFb and ephrin-B2-Fc combined, as indicated (mean ± SEM). n = 3, **p < 0.01
(C) Quantification of cell sorting in rat SCs transduced with adenoviruses encodin
absence or presence of LY2157299 (LY) and SD208 (SD) inhibitors, as indicated
(D) In vivo cell sorting in tdTom;Tgfbr2fl/fl and tdTom;Tgfbr2DSC in the bridge. Re
tdTom;Tgfbr2DSC at 6 days post-transection.
(E) Quantification of the in vivo cell sorting shown in panel D. Numbers of SCs in
bridges are shown (mean ± SEM). n = 6 for each genotype, **p < 0.01, Fisher’s e
(F) Boxplot of RNA-seq FPKM expression scores for Cdh2 in dSCs and bSCs. Co
extreme data point, which is no more than 1.53 the interquartile range from the
(G) qRT-PCR analysis ofCdh2 levels in bSCs and dSCs from single nerves 6 days
bars, n = 3–5). The whiskers extend to the most extreme data point, which is no
(H) Representative fluorescence images of N-cadherin protein levels in longitudin
(bottom) mice 6 days post-transection. P marks the proximal side and the arrow
112 Neuron 96, 98–114, September 27, 2017dependent manner to adapt SC function to the specific repair
requirements of their surrounding tissue.
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
Animals
Mice were bred and maintained in the animal care facility at Hammersmith Hospital. All animal procedures were carried out in accor-
dance with the Animal Scientific Procedures Act, 1986 and in accordance with the local ethical and care guidelines at Imperial Col-
lege London, Hammersmith Hospital and the International guidelines of the Home Office (UK). Mouse lines were obtained from the
Jackson Laboratory and the Riken BioResource. In order to specifically identify Schwann cells tdTomSC reporter mice were gener-
ated by crossing the protein myelin zero promoter specific cre recombinase mice P0A-Cre (Giovannini et al., 2000) obtained from
RIKEN BioResource Center (RBRCo1459) to B6.Cg-Gt(ROSA)26Sortm14(CAG-tdTomato)Hze mice (Madisen et al., 2010) obtained from
The Jackson Laboratory (Jax 007914), which express tdTomato after removal of a floxed stop codon under the control of the
Rosa promoter. In line with previous reports (Giovannini et al., 2000), Cre-mediated recombination led to 70%–95% of both myeli-
nating and nonmyelinating Schwann cells expressing tdTomato as assessed by staining of 10 mm tdTomSC nerve cryosections with
with Myelin basic protein and p75NGFR antibodies, respectively (Figures S1A and S1B). Deletion of TGFb signaling in nerves was
achieved by crossing P0A-Cre mice with Tgfbr2tm1Karl mice (Leve´en et al., 2002) obtained from The Jackson Laboratory (Jax
012603), which possess loxP sites flanking exon 4 of the Tgfbr2 gene to generate Tgfbr2DSC animals. Deletion of exon 4 leads to
a loss in TGFb signaling in 50%–85% of Schwann cells as assessed by genomic PCR and phospho-smad3 staining in the nerves
(Figures S4C and S4D). Tgfbr2DSC animals were also crossed to B6.Cg-Gt(ROSA)26Sortm14(CAG-tdTomato)Hze reporter mice to identify
recombined cells. 70%–90% of tdTomato+ Schwann cells were found to also carry Tgfbr2 recombination in these animals.
Sciatic nerve transections
Full sciatic nerve transections were carried out on male and female mice aged 6-8 weeks. The left sciatic nerve was exposed under
isoflurane general anesthesia in aseptic conditions and transected at a point 1cm from the sciatic notch. The incision was closed
using surgical clips and vetergesic analgesia was administered. Six days post-operation transected nerves, along with the contra-
lateral control nerve, were collected for subsequent studies. For proliferation studies, mice were injected intraperitoneally with EdU
(50mg/kg; Invitrogen) 4 hr prior to nerve collection. For the time course study nerves were collected at d1, d2, d4, d6, d8 and d10
post-transection.
Schwann Cell Cultures
Primary rat Schwann cells were prepared from p7 Sprague-Dawley rats (male and female). Sciatic nerves were dissected from pups,
finely chopped and digested in EBSS containing DNase (7 units), collagenase (1mg/ml) and 0.025% trypsin at 37C for 35 min.
Macrophages were removed from digested cells by panning with anti-CD11 antibody OX42 (Harlan sera-labs, MAS 370p) at
1:500 dilution. Fibroblasts were removed from the macrophage depleted cells by panning three times using Thy1 antibody (OX7
1:1000 BD Biosciences 554898). Rat Schwann cells were plated onto poly-L-lysine (1:2500) and laminin (1:100) coated dishes in
Schwann cell media (DMEM, GIBCO 11880-028) containing 3% FCS, 4mM glutamine, 1 mM forskolin, kanamycin/gentamycin
and GGF (Glial growth factor, manufactured in house).e4 Neuron 96, 98–114.e1–e7, September 27, 2017
Mouse Schwann cells were prepared from Tgfbr2fl/fl pups (male and female) at post-natal day 2. Sciatic and brachial nerves were
collected, digested in a 1:1 mixture of 0.4% collagenase type 2 (Worthington 405U/mg-4176) and trypsin 1:300 (GIBCO 840-7073
2.5mg/ml) in tilted 35 mm dish at 37C for 30-35 min. Cells were pelleted, suspended in dissociation medium (DMEM low glucose
from GIBCO 31885-023, 5% horse serum, arabinosylcytosine and penicillin/streptomycin and plated on poly-L-lysine (1:2500)
and laminin (1:100) coated dishes. After 3 days cells media was replaced with complete G5 medium: Neurobasal media
(ThermoFisher 21103049) containing 4mM glutamine, G5 supplement (ThermoFisher 17503012), heregulin (20ng/ml PreProtech
100-03), dibutryl-cyclic AMP (0.1mM Sigma D0260), kanamycin/gentamycin and 3% horse serum.
METHOD DETAILS
Preparation of mouse Schwann cells for FACS and RNA extraction
Transected nerves, or contralateral control nerves, from tdTomSC mice (male and female) were collected into ice-cold HEPES buff-
ered HBSS. The bridge region, and the nerve portion distal to the wound were separated from the proximal nerve by dissection under
a fluorescent stereomicroscope. In each dissection 90mm of nerve distal to the wound site was collected. For characterization of the
SC transcriptome shown in Figures 1, 2A–E, and 7F, nerves from 3 mice were pooled for each FACS sample. This yieldedR 250pg
RNA/sample enabling the generation of high coverage sequencing data. Bridges from 3mice were digested together while the distal
and intact nerves were digested separately and pooled prior to centrifugation. Nerve fractions were finely chopped prior to digestion
in a trypsin (GIBCO 1:250 3mg/ml): collagenase II (Worthington 1.62U/ul): hyaluronidase (Worthington 1%)mix 1:1:0.04 with the addi-
tion of pronase (Sigma-Aldrich 10%) 1 ml/50 ml. Nerves were digested for a total of 20 min at 37C with trituration after 10 min. Diges-
tion was terminated by trituration in dissociation medium (DMEM containing 5% horse serum and penicillin-streptomycin). Following
centrifugation (10 min, 1000rpm, 4C) cells were resuspended in 400 mL FACs sorting buffer containing 2.5% RNAsin (Promega).
tdTomato-expressing cells were FACs sorted (BD FACS ARIA III machine) and collected into RLT buffer (QIAGEN) along with
non-tdTomato-expressing cells and RNA was extracted using the RNeasy Plus Micro Kit according to manufacturer’s recommen-
dations (QIAGEN). For time-course analysis, RNA was extracted from single intact nerves as control, distal nerve stumps at d1,
d2 post-transection (no bridge is present at this stage) and both bridge and distal regions at d4, 6, 8 and 10.
Characterization of FACS sorted cells
FACS sorted cells were collected into 350ml of dissociation buffer which was transferred to a PLL coated 4 well plate in complete
Schwann cell media (Parrinello et al., 2010). The cells were allowed to adhere for 6 hr to overnight (37C with 10% CO2) and char-
acterized by immunofluorescence for S100b expression to determine purity of the Schwann cell preparation, or were stained with
Calcein AM (1:10,000 for 10 min, Sigma), to assess cell viability of the tdTomato+ cells. For quantitative assessment of purity, disso-
ciated tdTomato+ Schwann cells were acutely stainedwith S100-APC linked (1:50; Lightning-Link Innova Biosciences) and subjected
to FACS analysis to assess coexpression of S100b and tdTomato.
RNA-Sequencing Library Preparation
RNA libraries from FACS sorted cells were prepared from samples which had an RNA integrity number (RIN) greater than 7 and were
sufficiently concentrated to provide aminimumof 250pgRNA in amaximum volume of 2.4 ml. Samples were spikedwith ERCC spike-
in controls (Mix 1 ThermoFisher) at a dilution of 1:1x106. dsDNA libraries were prepared according to the Smart-seq2 protocol (Picelli
et al., 2014) and 1ng was tagmented using the Nextera XT DNA library preparation kit (Illumina) according to manufacturer’s instruc-
tions. The libraries were diluted to a final concentration of 2nM, the samples pooled and 10pmol were sequenced on an Illumina
HiSeq 2500 instrument. Time course RNA libraries were prepared from a minimum of 100pg of RNA with a RIN greater than 7.
Rat Schwann cell libraries were prepared fromRNA extracted using the Trizol method from control Schwann cells or Schwann cells
treated overnight with 10ng/ml recombinant TGFb (R&D Systems). 500ng of RNAwas used for library preparation using the NEBNext
Ultra Directional RNA library prep kit for Illumina (NEB). RNA sequencing was performed on pooled libraries as above.
RNA sequencing data was processed using RTA version 1.18.64, with default filter and quality settings. The reads were demulti-
plexed with CASAVA 1.8.4 (allowing 0 mismatches). Raw reads were aligned to mouse (NCBI Build 37, USCS mm9) or rat (RGSC
Rnor_5.0) genomes using the TopHat v.2.0.11 software (Kim et al., 2013b) and assigned to genomic features using HTSeq v.0.6.1
(Anders et al., 2015). RNA-seq data derived from single nerves were preprocessed by i) removing datasets containing less than
10000 detectable genes, ii) filtering out genes with less than 100 raw counts in more than 15% of the remaining datasets. After
filtering, 4 intact single nerves and 3 of each other conditions were included in our analysis, each containing data for > 6500 genes
(Table S6). Differential expression, RPKM, and normalized counts where generated using the DESeq2 Bioconductor package (Love
et al., 2014). Figures 1E and 3C are based on normalized counts and 2B on preranked ratios. Downstream data analysis was per-
formed in R. Functional analysis was performed using the DAVID and GSEA toolsets (Huang da et al., 2009; Subramanian et al.,
2005). Visualization of GO enrichments on Figure 1D was generated using the GOplot R package and outputs from DAVID (Walter
et al., 2015). Visualization of GSEA enrichment on Figure 2B was generated using R code made available from https://www.
biostars.org/p/168044/. ES modules were described in (Kim et al., 2010). Figure 1F represents the mean expression values in
FPKM from the iSC, dSC, and bSC datasets, mature astrocytes and neurons from (Zhang et al., 2014) and embryonic stem cells
from (Marks et al., 2012). FPKM from all datasets were further normalized by median centring to allow cross-comparison.SchwannNeuron 96, 98–114.e1–e7, September 27, 2017 e5
cell TGFb signaling signatures were defined by DESseq2 analysis of RNA-seq data from rat Schwann cells treated in vitrowith TGFb.
Signatures include genes up or downregulated more than 2 fold with an adjusted p value < 0.0001 (Table S5) (Love et al., 2014). The
list of 200 genes form the HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION available on the GSEA website was used as
EMT signature.
Cell Clustering Experiments and Infections
For clustering experiments, rat or mouse Schwann cells (2.8x104) were plated on PLL-treated coverslips which had been coated with
recombinant ephrinB2-Fc clustered with anti-Fc antibodies at a 2:1molar ratio (8ug/ml R&D Systems) at 37C overnight or with molar
equivalent anti-human Fc antibodies. Cells were plated in the presence or absence of 10ng/ml recombinant TGFb (R&DSystems) and
16 hr later fixed and stained for S100b (DAKO ZO311; 1:500) and N-cadherin (BD Biosciences 610921; 1:500). Quantification of cell
sorting was performed on duplicate coverslips. A minimum of 200 cells per coverslip was counted across randomly selected fields of
view. Two coverslips were counted for each condition. Cells were assigned to groups depending on whether they were single, in a
cluster of 2-9 cells or in a cluster of more than 9 cells and percentage of cells in clusters of increasing size calculated. N-cadherin at
cell-cell contacts was measured in ImageJ.
Samples for western blotting were plated at a density of 1.25 3 105 in 6-well plates previously coated with ephrinB2-Fc or Fc as
above in the presence or absence of 10ng/ml recombinant TGFb and collected after 16 hr in RIPA buffer. For inhibition of TGFR ac-
tivity cells were cultured in the presence or absence of two independent inhibitors; LY2157299 (Selleck; final concentration 5nM) and
SD208 (Tocris Bioscience; final concentration 2.5nM).
siRNA transfection of Schwann cells were performed For siRNA oligonucleotides were transfected using Hiperfect according
manufacturer’s instructions (QIAGEN). Silencing target sequences for Smad4 were: 50-CAGCTACTTACCACCATAACA-30 (oligo 1)
and 50-TCAGTAGCATTTGACTTAAA-30 (oligo 2), oligonucleotides were used at a final concentration of 25nM. For Cdh2 target
sequence was 50-CAGCGCGGTCTTACCGAAGGA-30 and was used at a final concentration of 4nM to produce partial knockdown.
N-cadherin rescue in rat Scwhann cells and deletion of Tgfbr2 in mouse cells was achieved by adenoviral infection. Tgfbr2fl/fl
mouse cells were transfected with adenoviruses encoding Cre recombinase. Control cells were infected with adenoviruses encoding
GFP (Ad-Gfp). Adenoviral supernatants were prepared as described in the manufacturer’s instructions (Vivapure-VivaScience) and
added at a multiplicity of infection of ?80 to Schwann cells. Twenty-four hours later the adenoviral supernatant was removed, and the
medium changed to fresh growth medium. Infection conditions were optimized to achieve maximal infection efficiency as judged by
the percentage of GFP-positive cells (> 95%) and minimal cell toxicity. Successful Tgfbr2 deletion was confirmed by qPCR
(Figure S4I).
Invasion Assays
Invasion of rat Schwann cells (2x105) through a 1:40 fibronectin matrix was carried out using the xCelligence system and CIM-Plates
16 (ACEA Biosciences) according to manufacturer’s instructions. Cells were cultured overnight in the presence or absence of
10ng/ml TGFb prior to seeding and invasion was allowed to proceed for 48 hr. Measurements were taken at the point of maximal
invasion, which corresponded to 4-6 hr after seeding.
For invasion ofmouse Schwann cells, 5x105 cells were placed in the upper well of BoydenChamber (Millicel 8.0 mmpore size) in the
presence or absence of TGFb (10ng/ml). Invasion through fibronectin-coated (1:40) membrane was allowed to proceed for 48 hr
before cells were fixed, stained with dapi (1:5000) and counted.
Immunofluorescence, Immunohistochemistry and Western Blotting
For quantifications of axonal regrowth and Schwann cell migration (Figure 4), cryo-sections (50 mm) of cut sciatic nerves were pro-
cessed for immunohistochemistry. Sections were thawed (10 min at room temperature), post-fixed (15 min 4% paraformaldehyde),
treated with NH4Cl2/glycine (0.2%/0.37%) before permeabilisation (3 hr in 1%NP-40 in TBST; tris-buffered saline with 0.1% tween
20). Sections were blocked and antibdodies added in TBST containing 10% donkey serum). All other immunostainings were carried
out on 15 mm cryo-sections. Antibodies were: anti-S100b (DAKO ZO311; 1:1000), chicken polyclonal anti-neurofilament (Abcam
ab72997 1:2000), sheep polyclonal anti-N-cadherin (R&D systems AF426 1:200), Myelin basic protein (MBP, Santa Cruz sc-13912
1:100) and p75NGFR (Millipore ab1554 1:1000). In addition, 5 mm paraffin sections were processed for phospho-smad3 (Abcam
ab52903 1:50) and S100b (DAKO ZO311 1:500) staining. To confirm the identity of psmad3 stained cells within the wound site
psmad3/S100b stained sections were also stained for fibroblasts (reticular fibroblast antibody1:500 ab51824) and endothelial cell
markers (endomucin 1:1000 sc65495). For identification of EdU incorporation 15 mm cryostat sections were stained using the
Click-It kit (Invitrogen) according to manufacturer’s instructions.
Western blotting and immunostaining of cells were performed according to standard protocols. Antibodies used for western blot-
ting were as follows: pEphB1/B2, rabbit polyclonal (Abcam ab61791 1:1000); EphB2, goat polyclonal (R&D Systems AF467 1:2000);
b-actin rabbit polyclonal (Abcam ab8227 1:5000); N-cadherin mouse monoclonal (BD Biosciences 610921; 1:1000); Smad4, rabbit
polyclonal (Millipore 04-1033; 1:1000). TGFb1 – rabbit polyclonal (1:1000 Abcam ab25121); TGFb2 – mouse polyclonal (1:1000
Abcam ab36495): phospho-smad2 – rabbit polyclonal (1:1000 Merck 566415); smad2 – mouse monoclonal (1:1000 Cell Signaling
Technology 3103S); gapdh – mouse monoclonal (1:10,000 Abcam ab9484): Sox2 – rabbit polyclonal (1:1000 Abcam ab97959);
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Quantitative RT-PCR
RNA was extracted from control Schwann cells or from Schwann cells treated overnight with 10ng/ml TGFb (R&D systems) using
Trizol Reagent (Ambion). Frozen nerve samples were homogenized in Trizol Reagent using a TissueRuptor (QIAGEN). RNA was
reverse transcribed using iScript gDNA clear cDNA synthesis kit (Bio-rad) and quantitative PCR was performed using the qPCRBIO
SyGreenMix Lo-Rox (PCRBiosystems). For quantitative RT-PCR from bridge and distal FACS-purified Schwann cells prepared from
transected nerves of Tgfbr2fl/fl or Tgrb2DSC mice, cDNA libraries were prepared according to the Smart-Seq2 protocol. RNA input
was 200pg for distal cells and 100pg for the bridge cells. Relative expression values for each gene of interest were obtained by
normalizing to B2M and plotted in R.
In vivo quantifications
Quantifications of Schwann cell migration and axonal regrowth were carried out on fluorescent images acquired using inverted SPE
confocal microscopes (Leica). 50 mm cryosections from Tgfbr2fl/fl and Tgfbr2DSC nerves were stained with S100b and/or neurofila-
ment and DAPI and for each nerve, the same volume and number of z- stacks was taken and the same settings of acquisition were
used. A projection of the z stacks was made and used for quantifications using Fiji software (http://fiji.sc/Fiji). For quantifications at
6 days post-transection, images of the 4 central sections of the bridge region of each nerve were taken and analyzed, as follows.
A horizontal line was drawn demarcating the boundary between proximal stump and bridge, as assessed by DAPI staining and
Schwann cell morphology. Lines perpendicular to this boundary were then drawn from the leading edge of each Schwann cord to
the boundary itself across the entire width of the nerve. Cord length was then averaged in each mouse to calculate ‘average cord
length’. Maximum migrated distance was also measured as the longest cord in each animal. For quantification of axonal regrowth
at 6 weeks post-transection, z stack images of distal stumps stained for neurofilament to identify axons were taken across the entire
width of the nerve. Projections were converted to binary images and area occupied by axons was measured as a readout of reinner-
vation. 3 areas of identical size were measured along the entire length of the distal stump at regular intervals from the wound site and
average axonal density calculated for each mouse. Quantifications of cell sorting were carried out in tdTom;Tgfbr2fl/fl and
tdTom;Tgfbr2DSC mice to facilitate visualization of bridge Schwann cells. Images of the proximal bridge were taken across the
four sections encompassing the central region of the nerve. Within each section, two areas of identical size were selected proximal
to the leading edge of the Schwann cell cords and number of Schwann cells in cords in each area quantified and expressed as per-
centage of total number of cell per area.
Electron microscopy and morphological analyses
Sciatic nerves were collected and fixed in 2% (vol/vol) glutaraldehyde in 0.12M phosphate buffer, post-fixed in 2% osmium tetroxide
overnight at 4C and in 2% Uranyl Acetate 45 min at 4C. Nerves were then dehydrated in an ethanol series before embedding in
epoxy resin.
Semithin sections were cut with a glass knife at 0.1 mm, dried carefully and stained with 0.5% toluidine blue in 2% borax at 75C for
30 s. After dehydration, sections were mounted with DPX (Sigma) and representative images were acquired using wide-field
microscopy.
Ultrathin sections were cut with a diamond knife at 70 nm, collected onto formvar coated slot grids, stained with lead citrate and
then visualized using transmission electron microscopy (T12 Tecnai Spirit, FEI) using a Morada camera and iTEM software
(Olympus SIS).
g ratios were determined by dividing the mean diameter of an axon without myelin by the mean diameter of the same axon with
myelin. To determine the size distribution of myelinated fibers, axon diameter of 9 images (three 75.58x50.34 microns fields per
mouse, 3mice per genotype) weremeasured and binned based on their diameter. All measurements were acquired using Photoshop
to draw the axons and their associated myelin sheath and Fiji software to measure their mean diameter.
QUANTIFICATION AND STATISTICAL ANALYSIS
Statistical analysis was performed using Prism (GraphPad Software). Fisher’s exact test was used for the clustering experiments;
Student’s t test was used for paired data and ANOVA with Bonferroni correction for all group data. All experiments for which quan-
tificationswere performedwere carried out aminimumof three times as indicated in the figure legends. Data are presented asmean ±
SEM p < 0.05 was considered significant.
DATA AND SOFTWARE AVAILABILITY
Gene expression data are available in the Gene Expression Omnibus, GEO: GSE103039. Freely available software and algorithms
used for analysis are listed in the resource table. Some unavailable analyses were specifically designed for the purpose of this paper
using routines written in R R version 3.3.1 (https://www.r-project.org/). All custom scripts and data contained in this manuscript are
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